Randomized Phase II Study of Vinflunine as Maintenance Monotherapy in Patients With Advanced or Metastatic Urothelial Cancer That Obtains Clinical Benefit of the First Line With Cisplatin-gemcitabine Combination
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Vinflunine (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
- Acronyms MAJA
- 04 Apr 2017 Results published in the Lancet Oncology
- 11 Oct 2016 Primary endpoint (Progression Free Survival) has been met, according to the results presented at the 41st European Society for Medical Oncology Congress
- 11 Oct 2016 Results presented at the 41st European Society for Medical Oncology Congress